Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Supraglottic Squamous Cell Carcinoma With Advance Technologies: Observational Evaluation of Quality of Life, Oncological Outcomes, Functional Outcomes and Economical Resources

NCT05611515 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire UCLouvain Namur as lead sponsor.

NCT NCT05611515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05611515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Supraglottic Squamous Cell Carcinoma With Advance Technologies: Observational Evaluation of Quality of Life, Oncological Outcomes, Functional Outcomes and Economical Resources
Lead sponsor
Centre Hospitalier Universitaire UCLouvain Namur
Phase
Observational
Overall status
Recruiting
Start date
June 17, 2022
Completion date
December 31, 2026
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage (t1-t2, n0-n1,m0), supraglottic squamous cell carcinoma